WallStreetZenWallStreetZen

NASDAQ: PAHC
Phibro Animal Health Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Phibro Animal Health earnings were $31.8M for the trailing 12 months ending Mar 31, 2025, with 139.4% growth year over year. The latest PAHC earnings report on Mar 31, 2025 announced Q1 2025 earnings of $20.9M, up 555.6% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, PAHC reported annual earnings of $2.4M, with -92.6% growth.

PAHC past earnings growth

How has PAHC's earnings growth performed historically?

Company
139.39%
Industry
3.02%
Market
36.45%
PAHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PAHC's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
PAHC's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

PAHC earnings history

Current Revenue
$1.2B
Current Earnings
$31.8M
Current Profit Margin
2.7%
PAHC's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PAHC Return on Equity

Current Company
12.4%
Current Industry
12.6%
Current Market
28.6%
PAHC's Return on Equity (12.4%)... subscribe to Premium to read more.
High Return on Equity Performance

PAHC undefined

Current Company
2.8%
Current Industry
6.6%
PAHC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PAHC announces earnings.

PAHC undefined

Current Company
7.74%
Current Industry
14%
PAHC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PAHC vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PAHC$123.68M$31.79M-2.36%$0.79
COLL$311.83M$43.89M+2.96%$1.36
HROW$18.65M-$21.70MN/A-$0.61
AVDL-$13.23M-$26.41MN/A-$0.27
CRON$9.12M$49.44M-44.29%$0.14
View Top Pharmaceutical Stocks

Phibro Animal Health Earnings Reports & History FAQ

What were Phibro Animal Health's earnings last quarter?

On PAHC's earnings call on Invalid Date, Phibro Animal Health (NASDAQ: PAHC) reported Q1 2025 earnings per share (EPS) of $0.52, up 147.62% year over year. Total PAHC earnings for the quarter were $20.88 million. In the same quarter last year, Phibro Animal Health's earnings per share (EPS) was $0.21.

If you're new to stock investing, here's how to buy Phibro Animal Health stock.

Is Phibro Animal Health profitable or losing money?

As of the last Phibro Animal Health earnings report, Phibro Animal Health is currently profitable. Phibro Animal Health's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $31.79 million, a 141.54% increase year over year.

What was PAHC's earnings growth in the past year?

As of Phibro Animal Health's earnings date in Invalid Date, Phibro Animal Health's earnings has grown 139.39% year over year. This is 136.37 percentage points higher than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 3.02%. PAHC earnings in the past year totalled $31.79 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.